This month, AMA Journal of Ethics' theme editor Cameron Waldman, a second-year medical student at Albany Medical College, interviewed Aron Janssen, MD, about how healthcare professionals can better serve their transgender patients.
The FDA's decision to put a black-box warning on antidepressant labels may be misleading because it implies that antidepressants have definitely been found to increase suicidality in adolescents, when in fact there is merely a lack of clear evidence about their safety.
The ad hoc capacity granted underage patients to consent to certain medical services cannot be allowed to thwart the reason it is granted in the first place—to protect the health of minors.
U.S. and international medical organizations recommend against testing children for genetic diseases that occur after adolescence and for which no prevention or treatment is available.
U.S. and international medical organizations recommend against testing children for genetic diseases that occur after adolescence and for which no prevention or treatment is available.
U.S. and international medical organizations recommend against testing children for genetic diseases that occur after adolescence and for which no prevention or treatment is available.
Physicians should recognize that patients’ beliefs may cause them to have non-medical explanations for their illnesses and that shared explanations should be negotiated if treatment plans are to be successful.
Current research suggests that the most effective treatment for pediatric depression is a combination of cognitive behavioral therapy and antidepressant medication, but continued funding for independent research is necessary.